Zobrazeno 1 - 10
of 37
pro vyhledávání: '"R P, Perrillo"'
Publikováno v:
Alimentary Pharmacology & Therapeutics. 20:23-28
Summary Background : Insulin sensitizing agents may be useful in treatment of non-alcoholic fatty liver disease. Aim : A pilot study to evaluate the efficacy and safety of metformin in non-alcoholic fatty liver disease. Methods : In an open labelled
Autor:
L B, Seeff, F B, Hollinger, H J, Alter, E C, Wright, C M, Cain, Z J, Buskell, K G, Ishak, F L, Iber, D, Toro, A, Samanta, R L, Koretz, R P, Perrillo, Z D, Goodman, R G, Knodell, G, Gitnick, T R, Morgan, E R, Schiff, S, Lasky, C, Stevens, R Z, Vlahcevic, E, Weinshel, T, Tanwandee, H J, Lin, L, Barbosa
Publikováno v:
Hepatology. 33:455-463
Persons with non-A, non-B hepatitis (cases) identified in 5 transfusion studies in the early 1970s have been followed ever since and compared for outcome with matched, transfused, non-hepatitis controls from the same studies. Previously, we reported
Publikováno v:
Alimentary pharmacologytherapeutics. 20(1)
Insulin sensitizing agents may be useful in treatment of non-alcoholic fatty liver disease.A pilot study to evaluate the efficacy and safety of metformin in non-alcoholic fatty liver disease.In an open labelled study, patients with histologically con
Publikováno v:
Clinical transplantation. 15
Here we describe a strategy for using livers from hepatitis B core antibody (anti-HBc) positive donors in anti-HBc negative recipients and report our preliminary results. Adult anti-HBc negative recipients were immunized against hepatitis B virus (HB
Autor:
R P, Perrillo
Publikováno v:
Clinical transplantation. 14
Hepatitis B infection of a liver allograft can have serious consequences including a negative influence on the probability of survival. Therefore, there is a need for very effective antiviral therapy for transplant recipients. In this article the ear
Publikováno v:
Seminars in liver disease. 20
Liver transplantation in patients infected with hepatitis B virus (HBV) commonly results in reinfection that, if untreated, often compromises the viability of the allograft and negatively influences survival. Posttransplant treatment with hepatitis B
Autor:
Z M, Younossi, R P, Perrillo
Publikováno v:
Seminars in liver disease. 19
Although alpha interferons are currently the standard treatments for chronic hepatitis C, they are effective in only 15% to 20% of patients. This low success rate has prompted research into new approaches for maximizing responses to alpha interferons
Autor:
R P, Perrillo
Publikováno v:
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 3(5 Suppl 1)
Publikováno v:
Digestive diseases and sciences. 42(1)
We studied the morbidity of chronic hepatitis C in patients referred to a tertiary care medical facility. The medical records of 500 consecutive cases of chronic hepatitis C were examined for the following: (1) source and time of exposure, (2) signs
Autor:
K L, Lindsay, G L, Davis, E R, Schiff, H C, Bodenheimer, L A, Balart, J L, Dienstag, R P, Perrillo, C H, Tamburro, J S, Goff, G T, Everson, M, Silva, W N, Katkov, Z, Goodman, J Y, Lau, G, Maertens, J, Gogate, B, Sanghvi, J, Albrecht
Publikováno v:
Hepatology (Baltimore, Md.). 24(5)
To evaluate response rates to 3, 5, or 10 million units (MU) of interferon alfa-2b, given thrice weekly, and to determine whether higher doses of interferon increase the likelihood or durability of the response, a multicenter, randomized trial was pe